Amgen Appoints Ronald D. Sugar to the Company's Board of Directors
Amgen announced that its board of directors has appointed Ronald D. Sugar to the company’s board, effective immediately. Dr. Sugar, 61, is chairman emeritus of Northrop Grumman Corp. and served as the company’s chairman and chief executive officer from 2003 to 2009. He was president and chief operating officer of Northrop from 2001 to 2003. He has been a director of Chevron Corporation since 2005.
Previously, Dr. Sugar was president, chief operating officer and a director of Litton Industries, chief financial officer of TRW Inc., and president and chief operating officer of TRW Aerospace.
In addition to his service on the Amgen board, Dr. Sugar will serve as a member of the Compensation and Management Development Committee and the Governance and Nominating Committee. His appointment brings the number of Amgen board members to 14.
Dr. Sugar is a member of the National Academy of Engineering, trustee of the University of Southern California, director of the Los Angeles Philharmonic Association and national trustee of the Boys and Girls Clubs of America.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
